Home > Insider Trading > Oncolytics Biotech Inc > Profile

Oncolytics Biotech Inc (ONCY)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Hedge Fund Popularity

Display

13F filing is ongoing

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on May 15, 2024, 4:01 pm based on SEC 13F filings Last update: May 15, 2024, 4:01 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Citadel Investment Group Ken Griffin	162,765	$172,531	+43%	0%
2.	Millennium Management Israel Englander	40,887	$43,340	-69%	0%
3.	Anson Investments Amin Nathoo And Moez Kassam	0	$0	-100%	0%

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Morgan Stanley	231,385	$312,370	0%
2.	International Assets Investment Management, Llc	199,777	$269,699	0.03%
3.	Advisor Resource Council	100,000	$135,000	0.01%
4.	Royal Bank Of Canada	54,925	$74,000	0%
5.	Geode Capital Management, Llc	41,942	$56,621	0%

News See All

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript

Operator: Good afternoon and welcome to Oncolytics Biotech's First Quarter 2024 Conference Call. [Operator Instructions]. Please be advised that this call is being recorded at the company's request.

Keep Reading →

May 10th, 2024 - News Transcripts

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2023 Conference Call. All participants are now in a listen-only mode.

Keep Reading →

March 10th, 2024 - News Transcripts

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Oncolytics Biotech's Third Quarter 2023 Conference Call. All participants are now in listen-only mode.

Keep Reading →

November 5th, 2023 - News Transcripts

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q2 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Oncolytics Biotech's Second Quarter 2023 Conference Call. All participants are now in listen-only mode.

Keep Reading →

August 15th, 2023 - News Transcripts

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2023 Earnings Call Transcript

Operator: Good morning. And welcome to Oncolytics Biotech's First Quarter 2023 Conference Call. All participants are now in listen-only mode.

Keep Reading →

May 7th, 2023 - News Transcripts

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2022 Earnings Call Transcript

Operator: Welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2022 Conference Call. Please be advised that this call is being recorded at the company's request.

Keep Reading →

March 6th, 2023 - News Transcripts

Is Oncolytics Biotech, Inc. (ONCY) A Good Stock To Buy?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Keep Reading →

November 26th, 2020 - Hedge Funds News

Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren't Crazy About It But Hedge Funds Love It

To the average investor, there are tons of indicators shareholders can use to watch publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading sentiment.

Keep Reading →

September 17th, 2013 - News

Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)

At the moment, there are tons of methods market participants can use to watch Mr. Market. A pair of the most useful are hedge fund and insider trading sentiment.

Keep Reading →

September 3rd, 2013 - News